PF-Atlas › Clinical Trials › NCT02275936

Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation

N91115 · Phase 1

Registry ID

NCT02275936

Phase

Phase 1

Status

Completed

Drug / intervention

N91115

Sponsor

Nivalis Therapeutics, Inc.

Start

2015-02

About this trial

N91115 is evaluated in NCT02275936, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Nivalis Therapeutics, Inc.. Current status: Completed.

View NCT02275936 on ClinicalTrials.gov →

Explore related

All N91115 trials All IPF trials

Related trials

N91115 — NCT02227888

Medical disclaimer. This page summarizes public trial data for NCT02275936 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.